Hypertension Targeting 120 mmHg: survival benefit after 3 years, but high renal risk

Area of Science:

• Cardiology
• Clinical Trials
• Public Health

Background:

• Hypertension management guidelines vary, impacting cardiovascular event risk.
• Previous research suggests benefits of stricter blood pressure control.

Purpose of the Study:

• To investigate the effect of intensive versus standard systolic blood pressure targets on mortality.
• To assess the safety profile of intensive blood pressure reduction.

Main Methods:

• A randomized trial involving patients aged 50+ at high cardiovascular risk.
• Comparison of an intensive systolic blood pressure target (around 120 mmHg) versus a standard target (around 135 mmHg).

Main Results:

• The intensive treatment group showed a reduction in all-cause mortality (3.3% vs. 4.5%) over approximately 3 years.
• Serious adverse effects, particularly renal issues, doubled in the intensive treatment group.
• The trial was not blinded.

Conclusions:

• Intensive systolic blood pressure lowering may reduce mortality in specific high-risk populations.
• The observed survival benefit must be weighed against a significant increase in adverse events.
• Findings are not generalizable to the broader hypertensive patient population due to specific inclusion criteria and adverse event profile.